Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M120,569Revenue $M32,839Net Margin (%)52.8Altman Z-Score5.1
Enterprise Value $M128,719EPS $11.7Operating Margin %65.4Piotroski F-Score5
P/E(ttm)7.6Beneish M-Score-2.5Pre-tax Margin (%)63.7Higher ROA y-yN
Price/Book8.610-y EBITDA Growth Rate %--Quick Ratio2.3Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %44.9Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow6.9y-y EBITDA Growth Rate %53.4ROA % (ttm)38.1Higher Current Ratio y-yN
Dividend Yield %2.0PEG0.2ROE % (ttm)104Less Shares Outstanding y-yY
Payout Ratio %11.0Shares Outstanding M1,367ROIC % (ttm)110Gross Margin Increase y-yY

Gurus Latest Trades with GILD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GILDT Rowe Price Equity Income Fund 2016-03-31 Add0.04%$82.71 - $101.19
($90.37)
$ 88.21-2%Add 8.29%1,353,600
GILDKen Fisher 2016-03-31 Reduce-0.01%$82.71 - $101.19
($90.37)
$ 88.21-2%Reduce -13.63%487,030
GILDT Rowe Price Equity Income Fund 2015-12-31 Buy 0.57%$97.54 - $110.96
($104.15)
$ 88.21-15%New holding1,250,000
GILDJulian Robertson 2015-12-31 Add0.55%$97.54 - $110.96
($104.19)
$ 88.21-15%Add 11.95%394,411
GILDDavid Dreman 2015-12-31 Sold Out -0.11%$97.54 - $110.96
($104.19)
$ 88.21-15%Sold Out0
GILDJohn Keeley 2015-12-31 Sold Out -0.08%$97.54 - $110.96
($104.19)
$ 88.21-15%Sold Out0
GILDJoel Greenblatt 2015-12-31 Reduce-0.06%$97.54 - $110.96
($104.19)
$ 88.21-15%Reduce -6.70%874,246
GILDKen Fisher 2015-12-31 Add$97.54 - $110.96
($104.15)
$ 88.21-15%Add 0.27%563,917
GILDMario Gabelli 2015-12-31 Reduce$97.54 - $110.96
($104.19)
$ 88.21-15%Reduce -2.40%42,700
GILDRonald Muhlenkamp 2015-12-31 Reduce$97.54 - $110.96
($104.19)
$ 88.21-15%Reduce -0.01%217,975
GILDNWQ Managers 2015-12-31 Reduce$97.54 - $110.96
($104.19)
$ 88.21-15%Reduce -1.53%166,900
GILDDodge & Cox 2015-12-31 Reduce$97.54 - $110.96
($104.19)
$ 88.21-15%Reduce -11.76%3,750
GILDJulian Robertson 2015-09-30 Reduce-0.78%$94.8 - $119.6
($111.06)
$ 88.21-21%Reduce -11.79%352,311
GILDJohn Rogers 2015-09-30 Add0.25%$94.8 - $119.6
($111.06)
$ 88.21-21%Add 18.71%1,313,500
GILDJoel Greenblatt 2015-09-30 Reduce-0.13%$94.8 - $119.6
($111.06)
$ 88.21-21%Reduce -12.28%936,982
GILDJohn Keeley 2015-09-30 Buy 0.08%$94.8 - $119.6
($111.06)
$ 88.21-21%New holding29,029
GILDKen Fisher 2015-09-30 Reduce-0.06%$94.8 - $119.6
($111.06)
$ 88.21-21%Reduce -28.96%562,391
GILDNWQ Managers 2015-09-30 Add0.04%$94.8 - $119.6
($111.06)
$ 88.21-21%Add 16.74%169,500
GILDDavid Dreman 2015-09-30 Add0.02%$94.8 - $119.6
($111.06)
$ 88.21-21%Add 17.88%11,228
GILDRonald Muhlenkamp 2015-09-30 Reduce-0.02%$94.8 - $119.6
($111.06)
$ 88.21-21%Reduce -0.29%217,990
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GILD is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GILD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Alton Gregg HEVP, Corp & Med Affairs 2016-04-19Sell40,000$100.01-11.8view
MILLIGAN JOHN FPresident and CEO 2016-04-04Sell112,000$94.59-6.74view
Carter Paul RutherfordEVP Commercial Ops 2016-04-01Sell2,000$91.34-3.43view
MARTIN JOHN CExecutive Chairman 2016-04-01Sell100,000$93.24-5.39view
Alton Gregg HEVP, Corp & Med Affairs 2016-04-01Sell5,000$91.23-3.31view
Alton Gregg HEVP, Corp & Med Affairs 2016-03-14Sell5,000$90-1.99view
Carter Paul RutherfordEVP Commercial Ops 2016-03-01Sell2,000$87.90.35view
MILLIGAN JOHN FPresident, COO and Director 2016-03-01Sell112,000$87.790.48view
MARTIN JOHN CChairman and CEO 2016-03-01Sell100,000$88.58-0.42view
WILSON GAYLE EDirector 2016-02-26Sell6,650$90.61-2.65view

Quarterly/Annual Reports about GILD:

News about GILD:

Articles On GuruFocus.com
Gilead, Fossil Among Stocks Trading Below Lynch Earnings Line Apr 13 2016 
Take 5: Consider Stocking Up on Gilead Sciences Apr 12 2016 
Weekly CEO Sells Highlight: Gilead Sciences, Boston Scientific, Sonic, HealthEquity Apr 10 2016 
Finding the Best Stocks to Invest In Mar 31 2016 
An Attempt to Value Valeant Just for Fun Mar 23 2016 
Gilead Sciences’ Miracle Drug Combination Mar 22 2016 
Gilead, Expedia Are Largely Undervalued Mar 17 2016 
Weekly CEO Sells Highlight: Motorcar Parts of America, The Interpublic Group of Companies, Gilead Sc Mar 07 2016 
A Look Back at 2 Successful Biotech Buyouts Feb 21 2016 
Valeant and Gilead's Growth Were Not Created Equal Feb 21 2016 

More From Other Websites
[$$] Gilead: The Deals Elephant Is in the Room Apr 29 2016
Gilead Judge Re-Opens Case Amid Claim Merck Scientist Lied Apr 29 2016
5 way to trade the mixed biotech sector Apr 29 2016
US STOCKS-Wall St falls as earnings weigh; Dow, S&P up for month Apr 29 2016
Amazon, LinkedIn Get PT Hikes; Baidu Upgraded, Gilead Sciences Cut Apr 29 2016
Looking for dividends Apr 29 2016
Maxim Cuts Gilead To Hold: Victim Of Its Own Success Apr 29 2016
Gilead drops, brings down S&P health care sector Apr 29 2016
A Typical Bad First Quarter For Biotech: Leerink Apr 29 2016
Gilead Stock: Analyzing 5 Key Suppliers (GILD) Apr 29 2016
Gilead Sciences Takes Lumps From Wall Street After Q1 Miss Apr 29 2016
What Are Analysts Saying About Q1 At Biotech's Big 4? Amgen, Biogen, Celgene, Gilead Apr 29 2016
[$$] Gilead: The Deals Elephant Is in the Room Apr 29 2016
Midday Report: Rovi Agrees to TiVo Acquisition; U.S. Stocks Slump Apr 29 2016
Gilead (GILD) Stock Plunges as Maxim Downgrades on Weak Q1 Earnings Apr 29 2016
Amazon, LinkedIn, Gilead, & More: Here’s Why These Stocks Are Trending Today Apr 29 2016
Gilead Says European CHMP Adopts Positive Opinion For Its Odefsey For Treating HIV Apr 29 2016
Stocks to Watch: AK Steel, TiVo, Amazon Apr 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)